Resistance Formation to Nitro Drugs in Giardia Lamblia: No Common Markers Identified by Comparative Proteomics

Overview

Journal Int J Parasitol Drugs Drug Resist

Publisher Elsevier

Specialty Parasitology

Date 2019 Mar 20

PMID 30889439

Citations 21

Authors

Joachim Muller

Sophie Braga

Manfred Heller

Norbert Muller

Affiliations

Soon will be listed here.

Abstract

In order to elucidate the question whether resistance to nitro drugs in G. lamblia is due to common resistance markers, trophozoites of three resistant G. lamblia strains, namely C4, 1062ID10, and 713M3 were grown in the presence of the two nitro drugs metronidazole and nitazoxanide and compared to their corresponding wild-types WBC6, 106, and 713 by mass spectometry shotgun analysis of their proteomes. Depending on the strain and the nitro drug, more than 200 to 500 differentially expressed proteins were identified, but there were no common patterns across strains and drugs. All resistant strains underwent antigenic variation with distinct surface antigens like variant surface proteins or cysteine rich proteins depending on strain and nitro compound. A closer look on enzymes involved in nitroreduction and detoxification of nitro radicals, NO or O suggested the existence of distinct strategies for each drug and each strain. Therefore, we conclude that resistance to nitro drugs in G. lamblia is not correlated with a specific pattern of differentially expressed proteins and therefore seems not to be the result of a directed process.

Citing Articles

Transient Adaptation of to Exposure by Thiosemicarbazone Drugs That Target Ribosomal Proteins Is Associated with the Upregulated Expression of Tachyzoite Transmembrane Proteins and Transporters.

Semeraro M, Boubaker G, Scaccaglia M, Muller J, Vigneswaran A, Hanggeli K Int J Mol Sci. 2024; 25(16).

PMID: 39201756 PMC: 11354806. DOI: 10.3390/ijms25169067.

Comprehensive analysis of flavohemoprotein copy number variation in Giardia intestinalis: exploring links to metronidazole resistance.

Korenkova V, Weisz F, Perglerova A, Caccio S, Nohynkova E, Tumova P Parasit Vectors. 2024; 17(1):336.

PMID: 39127700 PMC: 11316999. DOI: 10.1186/s13071-024-06392-5.

Investigating Antiprotozoal Chemotherapies with Novel Proteomic Tools-Chances and Limitations: A Critical Review.

Muller J, Boubaker G, Muller N, Uldry A, Braga-Lagache S, Heller M Int J Mol Sci. 2024; 25(13).

PMID: 39000012 PMC: 11241152. DOI: 10.3390/ijms25136903.

Assessment of Drug Activities against Using Hyperspectral Raman Microscopy.

Manciu F, Guerrero J, Pence B, Martinez Lopez L, Das S Pathogens. 2024; 13(5).

PMID: 38787210 PMC: 11124377. DOI: 10.3390/pathogens13050358.

Phylogenetic Analysis of Pyruvate-Ferredoxin Oxidoreductase, a Redox Enzyme Involved in the Pharmacological Activation of Nitro-Based Prodrugs in Bacteria and Protozoa.

Duwor S, Brites D, Maser P Biology (Basel). 2024; 13(3).

PMID: 38534448 PMC: 10968658. DOI: 10.3390/biology13030178.

References

Nillius D, Muller J, Muller N . Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother. 2011; 66(5):1029-35. DOI: 10.1093/jac/dkr029. View

Upcroft J, Upcroft P . Drug resistance and Giardia. Parasitol Today. 1993; 9(5):187-90. DOI: 10.1016/0169-4758(93)90144-5. View

Ankarklev J, Jerlstrom-Hultqvist J, Ringqvist E, Troell K, Svard S . Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol. 2010; 8(6):413-22. DOI: 10.1038/nrmicro2317. View

Upcroft J, Upcroft P, Boreham P . Drug resistance in Giardia intestinalis. Int J Parasitol. 1990; 20(4):489-96. DOI: 10.1016/0020-7519(90)90196-t. View

Leitsch D . A review on metronidazole: an old warhorse in antimicrobial chemotherapy. Parasitology. 2017; 146(9):1167-1178. DOI: 10.1017/S0031182017002025. View

Vicente J, Testa F, Mastronicola D, Forte E, Sarti P, Teixeira M . Redox properties of the oxygen-detoxifying flavodiiron protein from the human parasite Giardia intestinalis. Arch Biochem Biophys. 2009; 488(1):9-13. DOI: 10.1016/j.abb.2009.06.011. View

Einarsson E, Troell K, Hoeppner M, Grabherr M, Ribacke U, Svard S . Coordinated Changes in Gene Expression Throughout Encystation of Giardia intestinalis. PLoS Negl Trop Dis. 2016; 10(3):e0004571. PMC: 4807828. DOI: 10.1371/journal.pntd.0004571. View

Muller J, Hemphill A, Muller N . Physiological aspects of nitro drug resistance in Giardia lamblia. Int J Parasitol Drugs Drug Resist. 2018; 8(2):271-277. PMC: 6039359. DOI: 10.1016/j.ijpddr.2018.04.008. View

Upcroft J, CAMPBELL R, Benakli K, Upcroft P, Vanelle P . Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. Antimicrob Agents Chemother. 1998; 43(1):73-6. PMC: 89023. DOI: 10.1128/AAC.43.1.73. View

10.

Gargantini P, Serradell M, Torri A, Lujan H . Putative SF2 helicases of the early-branching eukaryote Giardia lamblia are involved in antigenic variation and parasite differentiation into cysts. BMC Microbiol. 2012; 12:284. PMC: 3566956. DOI: 10.1186/1471-2180-12-284. View

11.

Cernikova L, Faso C, Hehl A . Five facts about Giardia lamblia. PLoS Pathog. 2018; 14(9):e1007250. PMC: 6160191. DOI: 10.1371/journal.ppat.1007250. View

12.

Arguello-Garcia R, Cruz-Soto M, Gonzalez-Trejo R, Paz-Maldonado L, Bazan-Tejeda M, Mendoza-Hernandez G . An antioxidant response is involved in resistance of Giardia duodenalis to albendazole. Front Microbiol. 2015; 6:286. PMC: 4392323. DOI: 10.3389/fmicb.2015.00286. View

13.

Emery-Corbin S, Vuong D, Lacey E, Svard S, Ansell B, Jex A . Proteomic diversity in a prevalent human-infective Giardia duodenalis sub-species. Int J Parasitol. 2018; 48(11):817-823. DOI: 10.1016/j.ijpara.2018.05.003. View

14.

Ansell B, Baker L, Emery S, McConville M, Svard S, Gasser R . Transcriptomics Indicates Active and Passive Metronidazole Resistance Mechanisms in Three Seminal Lines. Front Microbiol. 2017; 8:398. PMC: 5355454. DOI: 10.3389/fmicb.2017.00398. View

15.

Rivero M, Kulakova L, Touz M . Long double-stranded RNA produces specific gene downregulation in Giardia lamblia. J Parasitol. 2010; 96(4):815-9. PMC: 2924914. DOI: 10.1645/GE-2406.1. View

16.

Muller J, Schildknecht P, Muller N . Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2). J Antimicrob Chemother. 2013; 68(8):1781-9. DOI: 10.1093/jac/dkt106. View

17.

Muller J, Hemphill A . New approaches for the identification of drug targets in protozoan parasites. Int Rev Cell Mol Biol. 2013; 301:359-401. DOI: 10.1016/B978-0-12-407704-1.00007-5. View

18.

Maayeh S, Knorr L, Svard S . Transcriptional profiling of Giardia intestinalis in response to oxidative stress. Int J Parasitol. 2015; 45(14):925-38. DOI: 10.1016/j.ijpara.2015.07.005. View

19.

Mastronicola D, Testa F, Forte E, Bordi E, Pucillo L, Sarti P . Flavohemoglobin and nitric oxide detoxification in the human protozoan parasite Giardia intestinalis. Biochem Biophys Res Commun. 2010; 399(4):654-8. DOI: 10.1016/j.bbrc.2010.07.137. View

20.

Muller J, Rout S, Leitsch D, Vaithilingam J, Hehl A, Muller N . Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds. Int J Parasitol Drugs Drug Resist. 2016; 5(2):37-43. PMC: 4813764. DOI: 10.1016/j.ijpddr.2015.03.001. View